A developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, including C. difficile, constipation-predominant irritable bowel syndrome and Pertussis.
I focus on swing trading as well as scalping. I trade trends and incorporate technical analysis. These rules make me money: Patience is key, do not chase, ignore FOMO and have a plan for every trade! Follow me on twitter: @drboblin
Wanda Halpert is the President of Concord Business Plans. Since 1997, she has led teams of researchers and financial analysts in the preparation of over 500 advanced Business Plans for public and private companies.
Managing four global allocation portfolios at GFG Capital with assets over $1 billion. Managed the Stetson University endowment as a trustee and equity/fixed income analyst. Small Cap analyst at KCM Asset Management, a long short hedge fund.